-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Scientists at the Klimbil Brain Institute have come up with a new model of the mechanism of Alzheimer's disease (AD2) that sees it as a chronic autoimmune disease that attacks the brain, rather than a brain disease
.
"We don't think Alzheimer's is fundamentally a brain disease
.
Alzheimer's disease is the most common dementia, affecting more than 50 million people worldwide, with a new patient diagnosed
every three seconds.
"We need new ways to think about this disease, and we need it now," Dr.
"But we believe β – amyloid is where it should be
.
Dr.
The team's findings point to the team's comprehensive search, combined with their own research, and an extensive review of journals and patient literature to develop a thorough model
of the mechanism of Alzheimer's disease.
1.
2.
Dr.
Donald F.
